Technology Transfer
SABC-HLP Network provides a strategic gateway between East and West, supporting the development, transfer, and clinical implementation of advanced stem cell and gene therapy technologies under international standards.
iPS Stem cell- Meaningful framework for Organ Regeneration & Repair strategies
Induced Pluripotent Stem Cell (iPSC)
SABC collaborates with leading international partners advancing clinical-stage iPSC-derived therapies for liver disorders, neurological diseases, and graft-versus-host disease (GvHD). These innovative approaches aim to promote tissue repair and regeneration directly within the body, expanding the future of regenerative medicine.
Extracellular Vesicles - Ideal biomaterials for regenerative nanomedicine applications
Owing to their natural targeting capability, low immunogenicity, biological stability, and ability to cross physiological barriers, EVs have emerged as promising next-generation therapeutics and diagnostic tools.
Through its open GMP-cGMP manufacturing platform, HLP supports the research, development, and scalable production of high-quality extracellular vesicle and exosome-based products for translational and clinical applications.
Photo: Robin L. Webb et al, Translational Stroke Research , 2018
Stem cell-Gene Editing : Cutting -Edge Cancer Figting Tools
Stem cell and gene-engineered immunotherapies represent a breakthrough in cancer treatment, harnessing the body's immune system to recognize and eliminate malignant cells. SABC aims to update next-generation cell and gene therapies, delivering innovative treatment solutions with the potential for durable, long-term cancer control and eradication.
Photo Medical College of Wisconsin, Oct 5th, 2020
Get in touch
Address
Hoa Lac High Tech Park
Thang Long Highway, km 26
Hoa Lac, Hanoi, Vietnam
84
info@hlpstem.com